Transfusion-associated graft versus host disease

Transfusion-associated graft versus host disease Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Transfusion-associated graft versus host disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Biomarker Panel
Chest X Ray
HLA analysis
Skin Punch Biopsy
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Transfusion-associated graft versus host disease On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Transfusion-associated graft versus host disease All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Transfusion-associated graft versus host disease
CDC on Transfusion-associated graft versus host disease
Transfusion-associated graft versus host disease in the news
Blogs on Transfusion-associated graft versus host disease
Directions to Hospitals Treating Transfusion-associated graft versus host disease
Risk calculators and risk factors for Transfusion-associated graft versus host disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Biomarker Panel | Chest X Ray | HLA Analysis | Skin Punch Biopsy | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1